4 research outputs found

    Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

    No full text

    World Congress Integrative Medicine & Health 2017: part two

    No full text

    World Congress Integrative Medicine & Health 2017: part two

    No full text
    corecore